Registro:

Referencias:

• Martens, E., Demain, A.L., The antibiotic resistance crisis, with a focus on the United States (2017) J. Antibiot., 70, pp. 520-526
• Fernandes, P., The global challenge of new classes of antibacterial agents: An industry perspective (2015) Curr. Opin. Pharmacol., 24, pp. 7-11
• Wenzel, R.P., The antibiotic pipeline-challenges, costs, values (2004) N. Engl. J. Med., 351, pp. 523-526
• Pundir, S., Magrane, M., Martin, M.J., O'Donovan, C., Searching and navigating UniProt Databases (2015) Curr. Protoc. Bioinform., p. 50. , The UniProt Consortium
• Wheeler, T.J., Eddy, S.R., Nhmmer: DNA homology search with profile HMMs (2013) Bioinformatics, 29, pp. 2487-2489
• Finn, R.D., Coggill, P., Eberhardt, R.Y., Eddy, S.R., Mistry, J., Mitchell, A.L., Potter, S.C., Sangrador-Vegas, A., The Pfam protein families database: Towards a more sustainable future (2016) Nucleic Acids Res., 44, pp. D279-D285
• Furnham, N., Holliday, G.L., De Beer, T.A.P., Jacobsen, J.O.B., Pearson, W.R., Thornton, J.M., The Catalytic Site Atlas 2.0: Cataloging catalytic sites and residues identified in enzymes (2013) Nucleic Acids Res., 42, pp. D485-D489
• Hopkins, A.L., Groom, C.R., The druggable genome (2002) Nat. Rev. Drug Discov., 1, pp. 727-730
• Cheng, A.C., Coleman, R.G., Smyth, K.T., Cao, Q., Soulard, P., Caffrey, D.R., Salzberg, A.C., Huang, E.S., Structure-based maximal affinity model predicts small-molecule druggability (2007) Nat. Biotechnol., 25, pp. 71-75
• Xie, L., Bourne, P.E., A robust and efficient algorithm for the shape description of protein structures and its application in predicting ligand binding sites (2007) BMC Bioinformatics, 8, p. S9
• Schmidtke, P., Le Guilloux, V., Maupetit, J., Tufféry, P., Fpocket: Online tools for protein ensemble pocket detection and tracking (2010) Nucleic Acids Res., 38, pp. W582-W589
• Schmidtke, P., Barril, X., Understanding and predicting druggability. A high-throughput method for detection of drug binding sites (2010) J. Med. Chem., 53, pp. 5858-5867
• Radusky, L., Defelipe, L.A., Lanzarotti, E., Luque, J., Barril, X., Marti, M.A., Turjanski, A.G., TuberQ: A Mycobacterium tuberculosis protein druggability database (2014) Database, 2014, p. 35
• Defelipe, L.A., Do Porto, D.F., Pereira Ramos, P.I., Nicolás, M.F., Sosa, E., Radusky, L., Lanzarotti, E., Marti, M.A., A whole genome bioinformatic approach to determine potential latent phase specific targets in Mycobacterium tuberculosis (2016) Tuberculosis, 97, pp. 181-192
• Zhang, R., DEG: A database of essential genes (2004) Nucleic Acids Res., 32, pp. D271-D272
• Luo, H., Lin, Y., Gao, F., Zhang, C.-T., Zhang, R., DEG 10, an update of the database of essential genes that includes both protein-coding genes and noncoding genomic elements (2014) Nucleic Acids Res., 42, pp. D574-D580
• Barh, D., Gupta, K., Jain, N., Khatri, G., Léon-Sicairos, N., Canizalez-Roman, A., Tiwari, S., Hassan, S.S., Conserved host-pathogen PPIs: Globally conserved inter-species bacterial PPIs based conserved host-pathogen interactome derived novel target in C. pseudotuberculosis, C. diphtheriae, M. tuberculosis, C. ulcerans, Y. pestis, E. coli targeted by Piper betel compounds (2013) Integr. Biol., 5, pp. 495-509
• Barh, D., Jain, N., Tiwari, S., Parida, B.P., D'Afonseca, V., Li, L., Ali, A., De Castro Soares, S., A novel comparative genomics analysis for common drug and vaccine targets in Corynebacterium pseudotuberculosis and other CMN group of human pathogens (2011) Chem. Biol. Drug Des., 78, pp. 73-84
• Kobayashi, K., Ehrlich, S.D., Albertini, A., Amati, G., Andersen, K.K., Arnaud, M., Asai, K., Bessieres, P., Essential Bacillus subtilis genes (2003) Proc. Natl. Acad. Sci. U.S.A., 100, pp. 4678-4683
• Albert, R., Scale-free networks in cell biology (2005) J. Cell Sci., 118, pp. 4947-4957
• Yeh, I., Hanekamp, T., Tsoka, S., Karp, P.D., Altman, R.B., Computational analysis of Plasmodium falciparum metabolism: Organizing genomic information to facilitate drug discovery (2004) Genome Res., 14, pp. 917-924
• Lacroix, V., Cottret, L., Thébault, P., Sagot, M.-F., An introduction to metabolic networks and their structural analysis (2008) IEEE/ACM Trans. Comput. Biol. Bioinform., 5, pp. 594-617
• Karp, P.D., Latendresse, M., Paley, S.M., Krummenacker, M., Ong, Q.D., Billington, R., Kothari, A., Subhraveti, P., Pathway Tools version 19.0 update: Software for pathway/genome informatics and systems biology (2016) Brief. Bioinform., 17, pp. 877-890
• Russell, J., Cohn, R., (2012) Cytoscape Book On Demand Limited, , California
• Skinner, M.E., Uzilov, A.V., Stein, L.D., Mungall, C.J., Holmes, I.H., J Browse: A next-generation genome browser (2009) Genome Res., 19, pp. 1630-1638
• Bairoch, A., The ENZYME database in 2000 (2000) Nucleic Acids Res., 28, pp. 304-305
• The Gene Ontology (GO) database and informatics resource (2004) Nucleic Acids Res., 32, pp. D258-D261. , Gene Ontology Consortium and Gene Ontology Consortium
• Ondov, B.D., Bergman, N.H., Phillippy, A.M., Interactive metagenomic visualization in a web browser (2011) BMC Bioinformatics, 12, p. 385
• Humphrey, W., Dalke, A., Schulten, K., VMD: Visual molecular dynamics (1996) J. Mol. Graph., 14, pp. 33-38
• Tiwari, N., Gedda, M.R., Tiwari, V.K., Singh, S.P., Singh, R.K., Limitations of current therapeutic options, possible drug targets and scope of natural products in control of leishmaniasis (2017) Mini Rev. Med. Chem., 17, pp. 182-189
• Chawla, B., Madhubala, R., Drug targets in Leishmania (2010) J. Parasit. Dis., 34, pp. 1-13
• Naula, C., Parsons, M., Mottram, J.C., Protein kinases as drug targets in trypanosomes and Leishmania (2005) Biochim. Biophys. Acta, 1754, pp. 151-159
• Brumlik, M.J., Pandeswara, S., Ludwig, S.M., Murthy, K., Curiel, T.J., Parasite mitogen-activated protein kinases as drug discovery targets to treat human protozoan pathogens (2011) J. Signal Transduct., 2011, p. 971968
• Barry, C.E., Crick, D.C., McNeil, M.R., Targeting the formation of the cell wall core of M. tuberculosis (2007) Infect. Disord. Drug Targets, 7, pp. 182-202
• Raman, K., Yeturu, K., Chandra, N., TargetTB: A target identification pipeline for Mycobacterium tuberculosis through an interactome reactome and genome-scale structural analysis (2008) BMC Syst. Biol., 2, p. 109
• Zavascki, A.P., Goldani, L.Z., Li, J., Nation, R.L., Polymyxin B for the treatment of multidrug-resistant pathogens: A critical review (2007) J. Antimicrob. Chemother., 60, pp. 1206-1215
• Ramos, P.I.P., Custódio, M.G.F., Quispe Saji, G.D.R., Cardoso, T., Da Silva, G.L., Braun, G., Martins, W.M.B.S., Fernández, E., The polymyxin B-induced transcriptomic response of a clinical, multidrug-resistant Klebsiella pneumoniae involves multiple regulatory elements and intracellular targets (2016) BMC Genomics, 17, p. 737
• Gao, Z., Li, H., Zhang, H., Liu, X., Kang, L., Luo, X., Zhu, W., Jiang, H., PDTD: A web-accessible protein database for drug target identification (2008) BMC Bioinformatics, 9, p. 104
• Zhu, F., Han, B., Kumar, P., Liu, X., Ma, X., Wei, X., Huang, L., Zheng, C., Update of TTD: Therapeutic Target Database (2010) Nucleic Acids Res., 38, pp. D787-D791
• Chen, L., Oughtred, R., Berman, H.M., Westbrook, J., TargetDB: A target registration database for structural genomics projects (2004) Bioinformatics, 20, pp. 2860-2862
• Magariñeos, M.P., Carmona, S.J., Crowther, G.J., Ralph, S.A., Roos, D.S., Shanmugam, D., Van Voorhis, W.C., Aguëro, F., TDR Targets: A chemogenomics resource for neglected diseases (2012) Nucleic Acids Res., 40, pp. D1118-D1127

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------